Verkazia (cyclosporine) NDC 82667-014

NDC codes

FDA NDC Directory

Product NDC (as listed)82667-014Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82667-0014Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82667-014-00	82667001400	5 POUCH in 1 CARTON (82667-014-00) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 1, 2025 · Sample package
82667-014-01	82667001401	24 POUCH in 1 CARTON (82667-014-01) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verkazia
Generic name (nonproprietary): cyclosporine
Active ingredients: Cyclosporine — 1 mg/mL
Dosage form: Emulsion
Route: Ophthalmic, Topical
Labeler: Harrow Eye, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 214965
Marketing start: Feb 1, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Calcineurin Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 82667-014_535cafb4-abf9-92cb-e063-6394a90aa3d0SPL ID 535cafb4-abf9-92cb-e063-6394a90aa3d0SPL set ID 48651d30-9e6e-74b0-e063-6294a90a8337RxCUI 2590608, 2590613UNII 83HN0GTJ6D
Pharmacologic class: Calcineurin Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic, Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482667001400 followed by a unit qualifier and the quantity

Package 82667-0014-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 3, 2026.

Indications (excerpt from the label)

Verkazia ophthalmic emulsion is indicated for the treatment of vernal keratoconjunctivitis (VKC) in children and adults. Verkazia ophthalmic emulsion is a calcineurin inhibitor immunosuppressant indicated for the treatment of vernal keratoconjunctivitis in children and adults ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 214965

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 214965
Product	Strength	Form · route	Labeler	Product NDC
Verkaziacyclosporine	Cyclosporine 1 mg/mL	EmulsionOphthalmic, Topical	Santen Incorporated	65086-001